Inmune Bio Inc stock is traded at $1.10, with a volume of 282,831. It is up 0.00% in the last 24 hours and down -41.80% over the past month. INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Previous Close:
$1.10
Open:
$1.11
24h Volume:
282,831
Relative Volume:
0.83
Market Cap:
$34.05M
Revenue:
$50,000
Net Income/Loss:
-$41.60M
P/E Ratio:
-
EPS:
-$1.69
Net Cash Flow:
-$20.20M
1W Performance:
-17.29%
1M Performance:
-41.80%
6M Performance:
-18.52%
1Y Performance:
-27.15%
1-Day Range:
$1.09$1.15
1-Week Range:
$1.06$1.30
52-Week Range:
$1.06$2.60
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 964-3720Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS